Similar articles

• Unjustified prescribing of CYP2D6 inhibiting SSRIs in women treated with tamoxifen.

  Binkhorst L, Mathijssen RH, van Herk-Sukel MP, Bannink M, Jager A, Wiemer EA, van Gelder T. Binkhorst L, et al. Breast Cancer Res Treat. 2013 Jun;139(3):923-9. doi: 10.1007/s10549-013-2585-z. Epub 2013 Jun 13. Breast Cancer Res Treat. 2013. PMID: 23760858
• Interaction of serotonin reuptake inhibitors with tamoxifen.

  Andersohn F, Willich SN. Andersohn F, et al. BMJ. 2010 Feb 8;340:c783. doi: 10.1136/bmj.c783. BMJ. 2010. PMID: 20142323 No abstract available.
• Tamoxifen-SSRIs interaction: clinical manifestations of inhibition and lack of inhibition of CYP2D6.

  Appiani F, Carroll BT, Muñoz C, Trecco J. Appiani F, et al. Ann Clin Psychiatry. 2011 May;23(2):152-3. Ann Clin Psychiatry. 2011. PMID: 21547277 No abstract available.
• Should CYP2D6 inhibitors be administered in conjunction with tamoxifen?

  Zembutsu H, Sasa M, Kiyotani K, Mushiroda T, Nakamura Y. Zembutsu H, et al. Expert Rev Anticancer Ther. 2011 Feb;11(2):185-93. doi: 10.1586/era.10.228. Expert Rev Anticancer Ther. 2011. PMID: 21342038 Review.
• Interactions between tamoxifen and antidepressants via cytochrome P450 2D6.

  Desmarais JE, Looper KJ. Desmarais JE, et al. J Clin Psychiatry. 2009 Dec;70(12):1688-97. doi: 10.4088/JCP.08r04856blu. J Clin Psychiatry. 2009. PMID: 20141708 Review.